Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 8/2020

01-08-2020 | Colonoscopy | Editorial

Is Tissue Really the Issue? How the Polyp Detection Rate May Be a Good Enough Quality Measure Among Trainees

Authors: Anthony J. Choi, SriHari Mahadev

Published in: Digestive Diseases and Sciences | Issue 8/2020

Login to get access

Excerpt

Although colonoscopy is unquestionably a powerful tool used for the prevention and early detection of colon cancer, there is growing awareness of the variability in the quality of screening colonoscopy, as a result of patient and endoscopist factors [1]. While several factors can be measured, the most important provider-specific indicator of colonoscopy quality is the adenoma detection rate (ADR), defined as the proportion of screening colonoscopies in which at least one adenoma is detected, which correlates inversely with the risk of interval colorectal cancer after colonoscopy [2]. Current benchmarks require an ADR of ≥ 20% and ≥ 30% in female and male patients, respectively. …
Literature
1.
Chen SC, Rex DK. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol. 2007;102:856–861.CrossRef
2.
Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298–1306.CrossRef
3.
Niv Y. Polyp detection rate may predict adenoma detection rate: a meta-analysis. Eur J Gastroenterol Hepatol. 2018;30:247–251.CrossRef
4.
Francis DL, Rodriguez-Correa DT, Buchner A, Harewood GC, Wallace M. Application of a conversion factor to estimate the adenoma detection rate from the polyp detection rate. Gastrointest Endosc. 2011;73:493–497.CrossRef
5.
Boroff ES, Gurudu SR, Hentz JG, Leighton JA, Ramirez FC. Polyp and adenoma detection rates in the proximal and distal colon. Am J Gastroenterol. 2013;108:993–999.CrossRef
6.
7.
See WA, Fisher RJ, Winfield HN, Donovan JF. Laparoscopic surgical training: effectiveness and impact on urological surgical practice patterns. J Urol. 1993;149:1054–1057.CrossRef
8.
Mahadev S, Jin Z, Lebwohl B, et al. Trainee colonoscopy quality is influenced by the independent and unobserved performance characteristics of supervising physicians. Endosc Int Open. 2019;7:E74–E82.CrossRef
9.
Yoon JY, Cha JM. Can we measure the learning curve of colonoscopy using polyp detection rate? Clin Endosc. 2016;49:6–7.CrossRef
Metadata
Title
Is Tissue Really the Issue? How the Polyp Detection Rate May Be a Good Enough Quality Measure Among Trainees
Authors
Anthony J. Choi
SriHari Mahadev
Publication date
01-08-2020
Publisher
Springer US
Keyword
Colonoscopy
Published in
Digestive Diseases and Sciences / Issue 8/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06151-3

Other articles of this Issue 8/2020

Digestive Diseases and Sciences 8/2020 Go to the issue

DDS AUTHOR PROFILES

Author Spotlight: Zoe Larghi Laureiro

Current Clinical Controversy

PPIs and Beyond: A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19

DDS AUTHOR PROFILES

Author Spotlight: Kelly E. Hathorn

Editorial

Next-Generation Sequencing (NGS) in the Prediction of Pancreatic Malignancy: Does Cell Free Mean Error Free?

Original Article

Role of Polymerase Chain Reaction in Stool and Duodenal Biopsy for Diagnosis of Giardiasis in Patients with Persistent/Chronic Diarrhea

Original Article

Quantification of Functional MR Predicts Early Response in Post-doxorubicin Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits